Sexually Transmitted Disease Therapeutics Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Sexually Transmitted Disease Therapeutics Market is expected to grow at a CAGR of 4.1% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Sexually Transmitted Disease Therapeutics Market. The market sizing is provided from 2017 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market.

The major key players of the market are as follows:

KEY PLAYERS

ABBOTT LABORATORIES

ABBVIE INC.

AGILENT TECHNOLOGIES, INC.

BECTON, DICKINSON AND COMPANY

BIOMERIEUX, INC.

BIO-RAD LABORATORIES, INC

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

BRISTOL-MYERS SQUIBB COMPANY

CEPHEID INC.

GILEAD SCIENCES, INC.

GLAXOSMITHKLINE PLC.

HOFFMANN-LA ROCHE INC.

HOLOGIC INC.

JANSSEN PHARMACEUTICALS, INC.

MERCK & CO., INC.

MERIDIAN LIFE SCIENCE INC.

NOVARTIS AG

PFIZER INC.

PROMEGA CORP.

QIAGEN N.V.

QUIDEL CORP

THERMO FISHER SCIENTIFIC, INC.

Scope of the Market

Disease Type Market

Chlamydia

Gonorrhea

Syphilis

Genital herpes

HPV

HIV/AIDS

.Others

Drug Type Market

Antibiotics

Antiviral/Antiretrovirals

Vaccines

Others

Diagnostic test types

Enzyme immunoassays (EIA)

ELISA

PCR

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)